Biotech Firms, Exec Pay $11M To Settle NJ Fraud Suit
A businessman and the New Jersey biotechnology companies he once ran will pay $11.2 million in restitution and civil penalties to settle state legal action over alleged securities violations, authorities announced...To view the full article, register now.
Already a subscriber? Click here to view full article